The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Plasmapheresis


Psychiatry related information on Plasmapheresis


High impact information on Plasmapheresis


Chemical compound and disease context of Plasmapheresis


Biological context of Plasmapheresis


Anatomical context of Plasmapheresis


Associations of Plasmapheresis with chemical compounds


Gene context of Plasmapheresis

  • Acute plasmapheresis in 11 of the 13 patients significantly increased the plasma clearance of TNF-alpha (P = .02) [31].
  • Based on these data, we would suggest a therapeutic approach in selected patients that includes the removal of serum inhibitory factors by plasmapheresis and restoration of cellular defects by combined IL-2 with or without INF-alpha [32].
  • Some reports have shown that patients with a very low plasma level of ADAMTS13 respond very well to plasmapheresis [33].
  • In the present study, a rapid and comprehensive method is presented to analyze IGFBPs and IGFBP fragments in the plasma of a child with acute renal failure (ARF) who had undergone plasmapheresis [34].
  • The protein A immunoadsorption column is a medical device that in conjunction with plasmapheresis can be used in patients with refractory RA [35].

Analytical, diagnostic and therapeutic context of Plasmapheresis


  1. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. Lewis, E.J., Hunsicker, L.G., Lan, S.P., Rohde, R.D., Lachin, J.M. N. Engl. J. Med. (1992) [Pubmed]
  2. Epoprostenol and plasmapheresis in complicated HELLP syndrome with pancreatitis. Huber, W., Schweigart, U., Classen, M. Lancet (1994) [Pubmed]
  3. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin. Ramage, J.K., Hale, A., Gane, E., Cohen, B., Boyle, M., Mufti, G., Williams, R. Lancet (1994) [Pubmed]
  4. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Dalakas, M.C., Engel, W.K. Ann. Neurol. (1981) [Pubmed]
  5. Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome. Dau, P.C., Denys, E.H. Ann. Neurol. (1982) [Pubmed]
  6. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. Elia, J., Dell, M.L., Friedman, D.F., Zimmerman, R.A., Balamuth, N., Ahmed, A.A., Pati, S. Journal of the American Academy of Child and Adolescent Psychiatry. (2005) [Pubmed]
  7. Plasma antithrombin III and plasminogen levels in chronic plasmapheresis. Jaffe, P., Mosher, D.F. N. Engl. J. Med. (1981) [Pubmed]
  8. In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Decreased enzyme catalytic efficiency in familial hypercholesterolemia. Stacpoole, P.W., Bridge, D.M., Alvarez, I.M., Goldberg, R.B., Harwood, H.J. J. Clin. Invest. (1987) [Pubmed]
  9. In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Studies in normal subjects. Harwood, H.J., Bridge, D.M., Stacpoole, P.W. J. Clin. Invest. (1987) [Pubmed]
  10. Plasmapheresis for severe, unremitting, chronic urticaria. Grattan, C.E., Francis, D.M., Slater, N.G., Barlow, R.J., Greaves, M.W. Lancet (1992) [Pubmed]
  11. Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin's disease. Braund, W.J., Naylor, B.A., Williamson, D.H., Buley, I.D., Clark, A., Chapel, H.M., Turner, R.C. Lancet (1987) [Pubmed]
  12. Hypersensitivity reaction to bacillus Calmette-Guérin treated with plasmapheresis. DeHertogh, D., Fierer, E., Orell, J.A. Am. J. Med. (1989) [Pubmed]
  13. Metabolic alkalosis due to plasmapheresis. Pearl, R.G., Rosenthal, M.H. Am. J. Med. (1985) [Pubmed]
  14. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Rodriguez, M., Karnes, W.E., Bartleson, J.D., Pineda, A.A. Neurology (1993) [Pubmed]
  15. Phenytoin removal by plasmapheresis in thrombotic thrombocytopenic purpura. Liu, E., Rubenstein, M. Clin. Pharmacol. Ther. (1982) [Pubmed]
  16. Gammopathy with proximal motor axonopathy simulating motor neuron disease. Parry, G.J., Holtz, S.J., Ben-Zeev, D., Drori, J.B. Neurology (1986) [Pubmed]
  17. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Cornblath, D.R., McArthur, J.C., Kennedy, P.G., Witte, A.S., Griffin, J.W. Ann. Neurol. (1987) [Pubmed]
  18. Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis. Fitchen, J.J., Cline, M.J., Saxon, A., Golde, D.W. Am. J. Med. (1979) [Pubmed]
  19. Imaging of the buffering effect of insulin antibodies in the autoimmune hypoglycemic syndrome. Dozio, N., Scavini, M., Beretta, A., Sarugeri, E., Sartori, S., Belloni, C., Dosio, F., Savi, A., Fazio, F., Sodoyez, J.C., Pozza, G. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  20. Aortic accumulation and plasma clearance of beta-VLDL and HDL: effects of diet-induced hypercholesterolemia in rabbits. Daugherty, A., Lange, L.G., Sobel, B.E., Schonfeld, G. J. Lipid Res. (1985) [Pubmed]
  21. Acute hemorrhagic leukoencephalitis. A successful recovery. Seales, D., Greer, M. Arch. Neurol. (1991) [Pubmed]
  22. Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor. Pintado, T., Taswell, H.F., Bowie, E.J. Blood (1975) [Pubmed]
  23. A prospective analysis of islet-cell cytotoxic antibodies in insulin-dependent diabetic children. Transient effects of plasmapheresis. Rabinovitch, A., MacKay, P., Ludvigsson, J., Lernmark, A. Diabetes (1984) [Pubmed]
  24. Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview. Clumeck, N., Hermans, P. Am. J. Med. (1988) [Pubmed]
  25. Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia. Ockelford, P.A., Hill, R.S., Nelson, L., Blacklock, H.A., Woodfield, D.G., Matthews, J.R. Transfusion (1982) [Pubmed]
  26. Plasmapheresis and Factor VIIIC inhibitors. Hambley, H., Watkins, R., Tansey, P.A., Walker, I.D., Davidson, J.F. Lancet (1985) [Pubmed]
  27. D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis--successful treatment with plasmapheresis and immunosuppressives. Matloff, D.S., Kaplan, M.M. Gastroenterology (1980) [Pubmed]
  28. Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Boumpas, D.T., Austin, H.A., Fessler, B.J., Balow, J.E., Klippel, J.H., Lockshin, M.D. Ann. Intern. Med. (1995) [Pubmed]
  29. The hepatopulmonary syndrome. Lange, P.A., Stoller, J.K. Ann. Intern. Med. (1995) [Pubmed]
  30. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Pestronk, A., Cornblath, D.R., Ilyas, A.A., Baba, H., Quarles, R.H., Griffin, J.W., Alderson, K., Adams, R.N. Ann. Neurol. (1988) [Pubmed]
  31. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. Gårdlund, B., Sjölin, J., Nilsson, A., Roll, M., Wickerts, C.J., Wretlind, B. J. Infect. Dis. (1995) [Pubmed]
  32. Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer. Wanebo, H.J., Blackinton, D., Kouttab, N., Mehta, S. Am. J. Surg. (1993) [Pubmed]
  33. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Shibagaki, Y., Fujita, T. Hypertens. Res. (2005) [Pubmed]
  34. IGF-binding protein-3 fragments in plasma of a child with acute renal failure. Schebek-Fürstenberg, V., Ständker, L., Oppermann, M., Müller-Wiefel, D.E., Hahn, W., Blum, W.F., Braulke, T., Kübler, B. Pediatr. Nephrol. (2004) [Pubmed]
  35. New therapeutic approaches to the management of rheumatoid arthritis. Hughes, L.B., Moreland, L.W. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. (2001) [Pubmed]
  36. Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial. Dwosh, I.L., Giles, A.R., Ford, P.M., Pater, J.L., Anastassiades, T.P. N. Engl. J. Med. (1983) [Pubmed]
  37. Progressive encephalomyelitis with rigidity responsive to plasmapheresis and immunosuppression. Fogan, L. Ann. Neurol. (1996) [Pubmed]
  38. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Euler, H.H., Schroeder, J.O., Harten, P., Zeuner, R.A., Gutschmidt, H.J. Arthritis Rheum. (1994) [Pubmed]
  39. Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjögren's syndrome. Konttinen, Y.T., Kinnunen, E., von Bonsdorff, M., Lillqvist, P., Immonen, I., Bergroth, V., Segerberg-Konttinen, M., Friman, C. Arthritis Rheum. (1987) [Pubmed]
WikiGenes - Universities